Categories: Uncategorized

Say Hello to 3.0: Datarithm Releases Latest Version of Inventory Management Solution

SYRACUSE, N.Y., Nov. 19, 2024 /PRNewswire/ — In a landscape marked by intense competition, rising costs, and stringent regulatory requirements, independent pharmacies face an array of challenges that threaten their viability and success. Today, Datarithm® is proud to announce a solution to these challenges with the latest release of its proprietary inventory management solution.

Datarithm Version 3.0 represents a culmination of nearly two years of dedicated effort to address the needs of independent pharmacies. This release introduces a range of enhancements and innovations designed to streamline operations, improve compliance, and empower pharmacies to thrive in a competitive market.

“We recognize the immense pressures our independent pharmacy clients are facing, from rising drugs costs to DIR fee changes, to managing cash flow and maintaining compliance,” said David Belinski, Datarithm President. “This is why we continue to invest in enhancing our software to help independent pharmacies better manage their inventory, operate more efficiently, and ultimately thrive in a fiercely competitive market.”

Key features and benefits of Datarithm Version 3.0 include:

- Advertisement -
  1. Revamped Dashboards, Key Performance Indicators (KPIs), and Settings Controls: Datarithm’s dashboards and KPIs have been fine-tuned to better highlight changes in your inventory profile, surplus position, service levels, and inventory balancing activity. All of the administrative consoles, where users can control forecasting, balancing recommendations, cycle count configuration, and application access have been retrofitted to be more intuitive and easier to navigate.
  2. Improved Task Wizards: Wizards for completing returns, transfers, liquidations, and cycle counts have been overhauled to make completion of these tasks easier and faster, ensuring that surplus inventory is reduced quickly with fewer errors.
  3. Enhanced Reporting and Analytics: We understand that data is only actionable if it is presented in a useful and intuitive way. Datarithm Version 3.0 comes with a more comprehensive set of out-of-the-box reports and charts highlighting surplus inventory, stock-outs/IOUs, balancing recommendations, and application usage by your staff—just to name a few. There is also a vastly improved custom report builder that allows you to build your own reports based on a variety of metrics.

For more information about Datarithm Version 3.0 and how it can benefit your pharmacy, visit our blog or schedule a demo. 

About Datarithm
Datarithm was founded in 2005 by a pharmacist, a software engineer, and a medical sales professional who joined forces to fill a gap in the independent pharmacy space. We share the belief that pharmacies are the first line of healthcare within our communities. As your ally, we pair the power of our inventory management platform with hands-on training, daily insights, and personalized guidance. You’ll get information you can act on as soon as tomorrow and financial results you can see in less than two weeks. With an intuitive dashboard, automated forecasting, inventory balancing, cycle counting, and advanced analytics, it’s never been easier to increase your pharmacy’s cash flow while putting time back in your staff’s day. Efficiently manage turns and fill rates and keep your business operating above the wellness line. Visit www.datarithm.co to schedule a no-obligation demo or call 877.273.5112 and start securing the future of your pharmacy today.

View original content:https://www.prnewswire.co.uk/news-releases/say-hello-to-3-0-datarithm-releases-latest-version-of-inventory-management-solution-302309425.html

Recent Posts

KFSHRC Madinahs Virtual Clinics Wins Award at PX Congress

RIYADH, Saudi Arabia, Nov. 20, 2024 (GLOBE NEWSWIRE) -- King Faisal Specialist Hospital and Research…

3 hours ago

IBA Business Update Third Quarter 2024

Louvain-la-Neuve, Belgium, 21 November 2024 - IBA (Ion Beam Applications S.A), the world leader in…

3 hours ago

Novartis upgrades mid-term guidance and highlights deep pipeline in core therapeutic areas to drive long-term growth

Ad hoc announcement pursuant to Art. 53 LR Mid-term sales guidance upgraded to +6% CAGR…

3 hours ago

Kura Oncology and Kyowa Kirin Announce Global Strategic Collaboration to Develop and Commercialize Ziftomenib in Acute Leukemias

– Kura to receive a $330 million upfront payment and up to $1.2 billion in…

3 hours ago

Onco360 Has Been Selected as a National Specialty Pharmacy Partner for Revuforj (revumenib)

LOUISVILLE, Ky., Nov. 20, 2024 (GLOBE NEWSWIRE) -- Onco360®, the nation’s leading independent Specialty Pharmacy,…

3 hours ago

Las Vegas Unveils Exclusive Entertainment, Packages and More for Race Week 2024

Destination Revving up This Year’s Excitement with Top-Tier Entertainment, Luxurious Trackside Experiences and Celebrations like…

6 hours ago